Literature DB >> 17979070

Death receptor-mediated liver injury.

Yuko Akazawa1, Gregory J Gores.   

Abstract

Apoptosis is a cardinal feature of liver injury. Death receptors are major mediators of the apoptotic pathway in the liver and have been implicated in the pathogenesis of diverse human diseases. More importantly, several studies have demonstrated a link between apoptosis and hepatic fibrosis; the latter is the most ominous consequence of chronic liver injury. In this article, we focus on the four death receptors: Fas, tumor necrosis factor receptor 1, tumor necrosis factor-related apoptosis-inducing ligand receptor 1, and tumor necrosis factor-related apoptosis-inducing ligand receptor 2. Although the death receptors have similar structures, they also possess distinct characteristics in their signaling pathways. Fas is abundantly expressed by all cells in the liver and plays a central role in variety of liver diseases. Tumor necrosis factor receptor 1 can induce both proapoptotic and prosurvival pathways. Tumor necrosis factor-related apoptosis-inducing ligand receptors likely trigger selective cell death in malignant and viral infected cells. Understanding the mechanism of liver injury caused by death receptors will enable therapeutic strategies to ameliorate human liver diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17979070     DOI: 10.1055/s-2007-991510

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  31 in total

1.  Genetic differences in oxidative stress and inflammatory responses to diet-induced obesity do not alter liver fibrosis in mice.

Authors:  Wing-Kin Syn; Liu Yang; Dian Jung Chiang; Yue Qian; Youngmi Jung; Gamze Karaca; Steve S Choi; Rafal P Witek; Alessia Omenetti; Thiago A Pereira; Anna Mae Diehl
Journal:  Liver Int       Date:  2009-04-20       Impact factor: 5.828

2.  Apoptosis and hepatic necroinflammation.

Authors:  Gregory J Gores
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-06

3.  Degradation of cIAPs contributes to hepatocyte lipoapoptosis.

Authors:  Yuko Akazawa; Maria Eugenia Guicciardi; Sophie C Cazanave; Steven F Bronk; Nathan W Werneburg; Keisuke Kakisaka; Kazuhiko Nakao; Gregory J Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-09-05       Impact factor: 4.052

4.  HBx activates FasL and mediates HepG2 cell apoptosis through MLK3-MKK7-JNKs signal module.

Authors:  Ren-Xian Tang; Fan-Yun Kong; Bao-Feng Fan; Xiao-Mei Liu; Hong-Juan You; Peng Zhang; Kui-Yang Zheng
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

Review 5.  Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver.

Authors:  Nam-On Ku; Pavel Strnad; Heike Bantel; M Bishr Omary
Journal:  Hepatology       Date:  2016-04-04       Impact factor: 17.425

Review 6.  Apoptosis as a mechanism for liver disease progression.

Authors:  Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Semin Liver Dis       Date:  2010-10-19       Impact factor: 6.115

7.  Amelioration of carbon tetrachloride-induced cirrhosis and portal hypertension in rat using adenoviral gene transfer of Akt.

Authors:  Gang Deng; Xiang-Jun Huang; Hong-Wu Luo; Fei-Zhou Huang; Xun-Yang Liu; Yong-Heng Wang
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

8.  Circulating and hepatic Fas expression in HCV-induced chronic liver disease and hepatocellular carcinoma.

Authors:  Azza E I El Bassiouny; Nora E I El-Bassiouni; Mona M F Nosseir; Mona M K Zoheiry; Eman G El-Ahwany; Faten Salah; Zeinab S O Omran; Raafat A Ibrahim
Journal:  Medscape J Med       Date:  2008-06-03

Review 9.  Glycosyltransferases and non-alcoholic fatty liver disease.

Authors:  Yu-Tao Zhan; Hai-Ying Su; Wei An
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

Review 10.  Apoptosis and necrosis in the liver.

Authors:  Maria Eugenia Guicciardi; Harmeet Malhi; Justin L Mott; Gregory J Gores
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.